(Press-News.org) Enzalutamide (trade name: Xtandi) has been approved since December 2014 for men who have metastatic prostate cancer that is not susceptible to hormone-blocking therapy, who have no symptoms or only mild ones, and in whom chemotherapy is not yet indicated. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
According to the findings, in comparison with watchful waiting the drug can prolong overall survival and delay the occurrence of disease complications. In men aged 75 years or older, IQWiG sees an indication of a major added benefit. There is also an indication of an added benefit in younger men; however, the extent is rated as "considerable".
Approval study terminated prematurely
The assessment was based on a randomized controlled trial (PREVAIL), which was the approval study for the indication described above. In this study, patients received either enzalutamide or a placebo, while the hormone-blocking medication was continued in all patients. In each study arm, treatment was continued until either the disease worsened (progression) or safety concerns arose, for example, because toxicity was too high.
As the interim analysis planned for the outcome "overall survival" had already shown good efficacy of enzalutamide, this was considered as the final Analysis.
Survival advantage depends on age
The difference in overall survival is statistically significant between the two study arms. However, as the further analysis of the data shows, this advantage is age dependent. It is greater in older men (75 years or more) than in younger ones. In each case, the IQWiG researchers derive an indication of an added benefit from these results, albeit with a different extent (major or minor).
Bone-related complications occur later
The study data also showed relevant group differences in favour of enzalutamide for other outcomes. For instance, bone-related complications occurred later in patients receiving enzalutamide than in those receiving placebo. IQWiG sees an indication of an added benefit here.
In addition, it took longer until opiates were used, that is, severe pain occurred later in patients receiving enzalutamide. This also applies to the occurrence of side effects (severe and serious adverse events) and the discontinuation of treatment due to side effects. Health-related quality of life also deteriorated later.
With regard to side effects, one finding was, however, unfavourable for enzalutamide: first-time hot flushes occurred earlier than under Placebo.
Different observation periods can reduce certainty of conclusions
Data were only recorded until the end of the study for the two outcomes "overall survival" and "bone-related complications". Data on all other outcomes were only recorded until the end of the randomized treatment period, which lasted 16.6 months in the enzalutamide group and 4.6 months in the placebo group (median values). This also means that, for these outcomes, the large differences in treatment and observation periods could have affected the results - and thus the certainty of conclusions.
However, at least for the outcome "discontinuation of treatment due to side effects", it can be excluded that the advantage of enzalutamide is only due to the different periods investigated. This is because in the placebo arm, which covered a shorter observation period, patients discontinued treatment more often than in the enzalutamide arm. IQWiG therefore sees an indication of an added benefit here. However, for the outcomes "side effects" and "quality of life" there is in each case a hint of an added benefit.
Negative effect does not challenge positive effects
Hot flushes occurred earlier in the enzalutamide arm; IQWiG derives a hint of greater harm from this finding. However, as hot flushes represent a "non-severe or non-serious adverse event", this negative effect does not challenge the otherwise positive effects of enzalutamide.
Overall, for patients aged 75 years and older, IQWiG sees an indication of a major added benefit; in younger patients, the extent of added benefit is rated as "considerable".
December 2013: dossier assessment of first therapeutic indication
IQWiG had already published the first dossier assessment of enzalutamide in December 2013, followed by an addendum in February 2014, which also considered data subsequently submitted by the manufacturer. However, the first assessment covered a different indication (metastatic prostate cancer, no longer susceptible to hormone-blocking therapy, and still progressing under docetaxel).
G-BA decides on the extent of added benefit
This dossier assessment is part of the early benefit assessment according to the Act on the Reform of the Market for Medicinal Products (AMNOG) supervised by the G-BA. After publication of the dossier assessment, the G-BA conducts a commenting procedure and makes a final decision on the extent of added benefit.
An overview of the results of IQWiG's benefit assessment is given by a German-language executive summary. In addition, the website » http://www.gesundheitsinformation.de, published by IQWiG, provides easily understandable German-language Information.
The G-BA website contains both general English-language information on the benefit assessment of new drugs pursuant to §35a Social Code Book (SGB) V and specific German-language information on the assessment of enzalutamide.
More English-language information will be available soon (Sections 2.1 to 2.6 of the dossier assessment as well as subsequently published health information on » http://www.informedhealthonline.org). If you would like to be informed when these documents are available, please send an e-mail to » info@iqwig.de.
INFORMATION:
Professor Jonathan Stamler's latest findings regarding nitric oxide have the potential to reshape fundamentally the way we think about the respiratory system - and offer new avenues to save lives. It may be time to rewrite the textbooks.
Scientific dogma has the respiration process involving only two elements -- oxygen and carbon dioxide. Specifically, the delivery of oxygen from lungs to tissues, and the removal of the waste product, carbon dioxide, through exhaling.
Recently published online in the journal Proceedings of the National Academy of Sciences (PNAS), Stamler ...
A simple and effective portable tool to predict avian flu outbreaks on farms has been created by University of Guelph researchers.
U of G researchers devised a real-time way to analyze chickens and other farm birds for avian flu. The tool uses a small blood sample and relies on a simple chemical colour change to see not only whether a chicken has avian flu but also what viral strain is involved.
Current tests require samples to be sent to a lab, where it can take eight hours to a couple of days to yield results. That's too long, said Prof. Suresh Neethirajan, School ...
CLEMSON, S.C. -- You're going to have to think very small to understand something that has the potential to be very big.
A team of researchers, including Kyle Brinkman of Clemson University, developed a material that acts as a superhighway for ions. The material could make batteries more powerful, change how gaseous fuel is turned into liquid fuel and help power plants burn coal and natural gas more efficiently.
The team reported its findings Friday in the journal Nature Communications.
Ye Lin, Shumin Fang and Fanglin Chen, all of the University of South Carolina, ...
Strategic partnering has become commonplace when introducing innovations to systems markets. In standards battles, network affiliation has been used as a market signal to create confidence in a format's success. This paper's authors thus develop and test a model aimed at finding the right partners to sponsor an innovative technology. The results suggest that company characteristics shape expectations about a system's future value and the likelihood of its survival. Partners that have proven successful in adjacent industries are especially suited to drive diffusion. Attracting ...
Major steps forward in the use of plants for renewable materials, energy and for building construction could soon arise, thanks to a key advance in understanding the structure of wood.
The step forward follows research by the Universities of Warwick and Cambridge and the unexpected discovery of a previously unknown arrangement of molecules in plant cell walls.
The paper describing this work was Editors' Choice for the American Chemical Society for March 25th.
The researchers investigated the polymer xylan, which comprises a third of wood matter.
Professor Ray ...
A study by researchers at The University of Manchester and the University of Liverpool has examined the psychological treatment of more than 300 people suffering from psychosis, showing that, whatever the therapy, it is the relationship between the patient and therapist which either improves or damages wellbeing.
The research relates to one of the more controversial ideas in psychotherapy research - the Dodo bird conjecture. Named after a bird in Alice's Adventures in Wonderland which sent several characters on a race and then declared them all winners, this conjecture ...
Consumers whose drinking water can be contaminated by the release of untreated wastewater after heavy rains face increased risk for gastrointestinal illness, according to a report in the journal Environmental Health Perspectives.
"Combined" sewer systems collect both sewage and stormwater runoff on the way to treatment facilities. When heavy rainfall fills these systems beyond their capacity, untreated wastewater can back up into homes. To reduce the risk of home flooding during heavy precipitation, municipalities often discharge some of the untreated flow into nearby ...
COLUMBUS, Ohio--A new study provides an inside look at the most powerful explosions in the universe: gamma-ray bursts.
These rare explosions happen when extremely massive stars go supernova. The stars' strong magnetic fields channel most of the explosion's energy into two powerful plasma jets, one at each magnetic pole. The jets spray energetic particles for light-years in both directions, at close to light speed.
On Earth, we detect bits of the resulting debris as gamma rays. Researchers also suspect--but haven't been able to prove conclusively--that GRBs are the source ...
Scientists from South Carolina's leading public universities--the University of South Carolina and Clemson University--have made a discovery that could dramatically improve the efficiency of batteries and fuel cells.
The research, which is published in the journal Nature Communications, involves improving the transport of oxygen ions, a key component in converting chemical reactions into electricity. The team studied a well-known material, gadolinium doped ceria (GDC), which transports oxygen ions and is currently in use as a solid oxide fuel cell electrolyte. Through ...
Washington, DC (April 10, 2015) - Using tech, like iPads, in schools has turned into a heated political debate. Los Angeles infamously spent $1.3 billion on a program to give iPads to each student that has subsequently been plagued with problems. In the United Kingdom the head of the National Association of Head Teachers claimed he was dubious about using tech as a teaching aid in non-IT classes. One solution could be using shared tech in classrooms. A promising study by a researcher at Northwestern University found that kindergartners in classes with shared iPads significantly ...
